A premium contract manfacturer of pharmaceutical active ingredients and advanced intermediates with plants in Switzerland. In its cGMP operated and FDA inspected plant, the company has developed a sound know-how in complex organic synthesis. The company is experienced in new projects from clinical development phases into launch and marketing phases (API's and HPAI's). Helsinn is building a plant that will be dedicated to the Develpment, Analysis and Manufacturing (small and large scale) of Cytotoxic molecules.